Influence of GSTP1 I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma. - Wikidata - awgldk - TriplyDB

Influence of GSTP1 I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma.

Influence of GSTP1 I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma.

http://www.wikidata.org/entity/Q27851530

about

Mechanisms involved in the development of chemotherapy-induced neuropathy FOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapy CIViC database Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis.ERCC1, XRCC1 and GSTP1 Single Nucleotide Polymorphisms and Survival of Patients with Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy.A DPYD variant (Y186C) specific to individuals of African descent in a patient with life-threatening 5-FU toxic effects: potential for an individualized medicine approach.Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years Glutathione S-transferase Pi expression predicts response to adjuvant chemotherapy for stage C colon cancer: a matched historical control study.Association between GSTP1 Ile105Val polymorphism and oxaliplatin-induced neuropathy: a systematic review and meta-analysis.Candidate pathway-based genetic association study of platinum and platinum-taxane related toxicity in a cohort of primary lung cancer patients.Association between the ERCC1 rs11615 polymorphism and clinical outcomes of oxaliplatin-based chemotherapies in gastrointestinal cancer: a meta-analysis Platinum-induced neurotoxicity and preventive strategies: past, present, and future Informative gene network for chemotherapy-induced peripheral neuropathy Using Molecular Markers to Guide Therapy of Metastatic Colorectal Cancer Single nucleotide polymorphisms in glutathione S-transferase P1 and M1 genes and overall survival of patients with ovarian serous cystadenocarcinoma treated with chemotherapy Tumor site- and stage-specific associations between allelic variants of glutathione S-transferase and DNA-repair genes and overall survival in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy Can GSTM1 and GSTT1 polymorphisms predict clinical outcomes of chemotherapy in gastric and colorectal cancers? A result based on the previous reports.A phase II clinical study of mFOLFOX6 plus bevacizumab as first-line therapy for Japanese advanced/recurrent colorectal cancer patients A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen.Part 3: Pharmacogenetic variability in phase II anticancer drug metabolism.Pharmacogenomics and metastatic colorectal cancer: current knowledge and perspectives.XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis.X-ray repair cross-complementing 1 polymorphism and prognosis of platinum-based chemotherapy in gastric and colorectal cancer: a meta-analysis.Personalizing colon cancer therapeutics: targeting old and new mechanisms of action.Predictive value of GSTP1 Ile105Val polymorphism in clinical outcomes of chemotherapy in gastric and colorectal cancers: a systematic review and meta-analysis.Nucleotide excision repair and response and survival to chemotherapy in colorectal cancer patients.Long-term administration and efficacy of oxaliplatin with no neurotoxicity in a patient with rectal cancer: Association between neurotoxicity and the GSTP1 polymorphism.Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients.Large-scale prospective pharmacogenomics study of oxaliplatin-induced neuropathy in colon cancer patients enrolled in the JFMC41-1001-C2 (JOIN Trial).SNPs in transporter and metabolizing genes as predictive markers for oxaliplatin treatment in colorectal cancer patients.Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy.AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin.Polymorphisms of GSTP1, ERCC2 and TS-3'UTR are associated with the clinical outcome of mFOLFOX6 in colorectal cancer patients.Human mu-opioid receptor gene A118G polymorphism predicts the efficacy of tramadol/acetaminophen combination tablets (ultracet) in oxaliplatin-induced painful neuropathy.Lack of association between XPD Lys751Gln and Asp312Asn polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.VEGF -460T → C polymorphism and its association with VEGF expression and outcome to FOLFOX-4 treatment in patients with colorectal carcinoma.Endostar in combination with modified FOLFOX6 as an initial therapy in advanced colorectal cancer patients: a phase I clinical trial.SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand.

P2860

Q26824380-FDC6778B-0BC1-4969-A3CE-8E979E363ACA Q26851060-FBC2A50B-8673-4232-8772-3D9B1CAE5948 Q27612411-1E751C63-6B14-4611-95B4-19575ED51D6F Q33391561-1D656797-209E-4885-BAC7-F47A57BD1882 Q33634975-23AC319E-08DC-4D2F-A7AF-4A7948201495 Q33810014-E8AE5B5F-86BD-4895-BEC0-0A03E6D075AA Q34008793-71B65FB5-9CC5-44BC-9B4B-45EA761F3C5E Q34284168-66835FE3-B5BF-4834-B19B-3D7997DEC1A9 Q34733071-79F2BA50-75E3-43E8-BA62-BB6D9DFABC4A Q35100937-D3E6C411-E437-48E0-B017-B9E2EA0C921D Q35194655-59A95B0A-23AA-4339-94F6-7B2D63077C78 Q35345734-C7305295-4D53-478B-B4E8-B7E4A11A23B1 Q35945680-59E21CE1-D88D-4AF7-B8D3-77E66613D82B Q36341759-79290809-E809-48DB-B808-7DC12F26F49A Q36741735-B76E1C36-F761-4B4B-A3E2-936583D687FE Q37039153-F079AD2A-7720-4170-8F0D-9632971DB2A4 Q37042575-5ECD533A-F57A-47C8-8E42-A97356D22748 Q37272489-E790C6E9-421B-4058-8810-1EB5A05397BE Q37383249-AF4ED6D8-1086-49B4-BB1E-2A7D8247EE30 Q37887337-CB80733F-4A6C-48F5-BED6-7A80F47AFF03 Q37969851-4975F355-4B12-4D48-8A82-E972E062ADC9 Q38072637-0A68C2A7-EAA9-418C-A0A0-4D913A5AC843 Q38162285-E20A3960-FD45-464C-A0CF-102BD654E34B Q38166233-F933B092-B069-426A-869F-2FEBF9B078DE Q38827826-E204581A-A2EB-4E6C-914C-1AB1904AE065 Q38835268-2825312E-6965-470B-B111-019A5E50FA52 Q38932560-44308A10-8962-4D91-A8D7-1DADB0FFA5FE Q39566084-57673908-8888-40A1-B755-8C882784E092 Q39858558-0684AACD-4E52-4E9D-B05F-69A4487F3150 Q40936032-D174CA8E-FBBC-4523-8A8B-7FA22E0BF9DD Q41442402-D3C0BC5A-71E4-45A7-94E3-5CFB8B1002F7 Q41495258-5BD47344-3DB1-4632-AB4B-41B58C1361D3 Q42205484-689E86D3-EF6C-459F-BA72-E699580E0441 Q44174442-AAB30436-02B6-4D57-85A9-AE2678635590 Q44690550-6288434C-82E5-4CB3-8FB3-30A2239CB42E Q45234431-3C39B637-1130-47C3-86BC-D1EFCFC67A59 Q50594918-91DD7C8D-FECF-4EC8-A6DD-1F1A3BD22F2C Q55497899-6E35866A-3E2E-48FD-B73F-D3EE8FBAB21D

P2860

Influence of GSTP1 I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma.

http://www.wikidata.org/entity/Q27851530

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Influence of GSTP1 I105V polym ...... nts with colorectal carcinoma.

@ast

Influence of GSTP1 I105V polym ...... nts with colorectal carcinoma.

@en

Influence of GSTP1 I105V polym ...... nts with colorectal carcinoma.

@nl

type

label

Influence of GSTP1 I105V polym ...... nts with colorectal carcinoma.

@ast

Influence of GSTP1 I105V polym ...... nts with colorectal carcinoma.

@en

Influence of GSTP1 I105V polym ...... nts with colorectal carcinoma.

@nl

prefLabel

Influence of GSTP1 I105V polym ...... nts with colorectal carcinoma.

@ast

Influence of GSTP1 I105V polym ...... nts with colorectal carcinoma.

@en

Influence of GSTP1 I105V polym ...... nts with colorectal carcinoma.

@nl

P1433

Q27851530-E72047F5-4D4E-4503-A794-688BDE127B91

P1476

Q27851530-F918784E-4E7A-4037-83E4-6480B26AD3AF

P2093

Q27851530-0C573A97-B456-4B65-910A-06C7B20F072D

Q27851530-2902BE2F-E86A-4357-A71E-770EC3FA4C17

Q27851530-439BE978-098D-4FE5-83BE-7FB8B1009117

Q27851530-553378FE-395B-45DF-A125-4E5FEAB4A4F0

Q27851530-6A674F7A-B1FF-44D0-9E95-6C8626AFD9BD

Q27851530-707A7E31-BD1B-432B-9CB3-10B2D9B1465D

Q27851530-9803B87A-5339-4525-84DD-2F9E191EF4A4

Q27851530-BAF68B63-077F-4680-9225-5FE2DB3D7BA1

Q27851530-EB090E6C-3ED6-4317-BF8D-98AB38B8AA4F

P2860

Q27851530-1B211AB1-7748-4CE3-B6D9-369CB7C8F3AE

Q27851530-64404EA8-BEBC-4382-8CF5-61BA3CAE5ECA

P304

Q27851530-55D8137D-FD2F-49EB-B140-B134257FB2ED

P31

Q27851530-2BB46B48-01E7-43E8-9BCD-216631D68236

P3181

Q27851530-801FE537-3297-47DA-8EBF-0565229BB89F

P356

Q27851530-FDCBF367-709B-468F-B658-8427FA5CEEFE

P433

Q27851530-8A73E0B0-E8AE-47CD-AEE3-059E375BB2A3

P478

Q27851530-3A96E684-92E0-4B36-AABE-250651532DBB

P577

Q27851530-38301204-A50B-40E9-AE6B-3CD470B7B3AD

P5875

Q27851530-7653F005-6D7A-4697-A045-300D2BFE7A0B

P698

Q27851530-9255FA47-C528-433A-8C7C-FDEA0FA95DDD

P3181

P356

J.1349-7006.2009.01418.X

P1433

P1476

Influence of GSTP1 I105V polym ...... nts with colorectal carcinoma.

@en

P2093

Cheng-Hwai Tzeng

http://www.w3.org/2001/XMLSchema#string

Huann-Sheng Wang

http://www.w3.org/2001/XMLSchema#string

Jen-Kou Lin

http://www.w3.org/2001/XMLSchema#string

Jeng-Kae Jiang

http://www.w3.org/2001/XMLSchema#string

Po-Min Chen

http://www.w3.org/2001/XMLSchema#string

Tzu-Chen Lin

http://www.w3.org/2001/XMLSchema#string

Wei-Shone Chen

http://www.w3.org/2001/XMLSchema#string

Wei-Shu Wang

http://www.w3.org/2001/XMLSchema#string

Yen-Chung Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Zeta, a novel class of glutathione transferases in a range of species from plants to humans

Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer.

P304

530-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

620857

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/J.1349-7006.2009.01418.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38098261

http://www.w3.org/2001/XMLSchema#string

P698

19922504

http://www.w3.org/2001/XMLSchema#string